These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 23886027

  • 1. A randomized double blind placebo controlled clinical trial of N-Acetylcysteine added to risperidone for treating autistic disorders.
    Ghanizadeh A, Moghimi-Sarani E.
    BMC Psychiatry; 2013 Jul 25; 13():196. PubMed ID: 23886027
    [Abstract] [Full Text] [Related]

  • 2. N-acetylcysteine as an adjunctive therapy to risperidone for treatment of irritability in autism: a randomized, double-blind, placebo-controlled clinical trial of efficacy and safety.
    Nikoo M, Radnia H, Farokhnia M, Mohammadi MR, Akhondzadeh S.
    Clin Neuropharmacol; 2015 Jul 25; 38(1):11-7. PubMed ID: 25580916
    [Abstract] [Full Text] [Related]

  • 3. Riluzole as an adjunctive therapy to risperidone for the treatment of irritability in children with autistic disorder: a double-blind, placebo-controlled, randomized trial.
    Ghaleiha A, Mohammadi E, Mohammadi MR, Farokhnia M, Modabbernia A, Yekehtaz H, Ashrafi M, Hassanzadeh E, Akhondzadeh S.
    Paediatr Drugs; 2013 Dec 25; 15(6):505-14. PubMed ID: 23821414
    [Abstract] [Full Text] [Related]

  • 4. l-Carnosine As an Adjunctive Therapy to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Hajizadeh-Zaker R, Ghajar A, Mesgarpour B, Afarideh M, Mohammadi MR, Akhondzadeh S.
    J Child Adolesc Psychopharmacol; 2018 Feb 25; 28(1):74-81. PubMed ID: 29027815
    [Abstract] [Full Text] [Related]

  • 5. Minocycline as Adjunctive Treatment to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind Placebo-Controlled Trial.
    Ghaleiha A, Alikhani R, Kazemi MR, Mohammadi MR, Mohammadinejad P, Zeinoddini A, Hamedi M, Shahriari M, Keshavarzi Z, Akhondzadeh S.
    J Child Adolesc Psychopharmacol; 2016 Nov 25; 26(9):784-791. PubMed ID: 27128958
    [Abstract] [Full Text] [Related]

  • 6. Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial.
    Aman M, Rettiganti M, Nagaraja HN, Hollway JA, McCracken J, McDougle CJ, Tierney E, Scahill L, Arnold LE, Hellings J, Posey DJ, Swiezy NB, Ghuman J, Grados M, Shah B, Vitiello B.
    J Child Adolesc Psychopharmacol; 2015 Aug 25; 25(6):482-93. PubMed ID: 26262903
    [Abstract] [Full Text] [Related]

  • 7. Initial severity and efficacy of risperidone in autism: Results from the RUPP trial.
    Levine SZ, Kodesh A, Goldberg Y, Reichenberg A, Furukawa TA, Kolevzon A, Leucht S.
    Eur Psychiatry; 2016 Feb 25; 32():16-20. PubMed ID: 26802979
    [Abstract] [Full Text] [Related]

  • 8. Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.
    Asadabadi M, Mohammadi MR, Ghanizadeh A, Modabbernia A, Ashrafi M, Hassanzadeh E, Forghani S, Akhondzadeh S.
    Psychopharmacology (Berl); 2013 Jan 25; 225(1):51-9. PubMed ID: 22782459
    [Abstract] [Full Text] [Related]

  • 9. Simvastatin as an Adjunctive Therapy to Risperidone in Treatment of Autism: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Moazen-Zadeh E, Shirzad F, Karkhaneh-Yousefi MA, Khezri R, Mohammadi MR, Akhondzadeh S.
    J Child Adolesc Psychopharmacol; 2018 Feb 25; 28(1):82-89. PubMed ID: 28719227
    [Abstract] [Full Text] [Related]

  • 10. Risperidone Combination Therapy With Propentofylline for Treatment of Irritability in Autism Spectrum Disorders: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Behmanesh H, Moghaddam HS, Mohammadi MR, Akhondzadeh S.
    Clin Neuropharmacol; 2019 Feb 25; 42(6):189-196. PubMed ID: 31725473
    [Abstract] [Full Text] [Related]

  • 11. A head-to-head comparison of aripiprazole and risperidone for safety and treating autistic disorders, a randomized double blind clinical trial.
    Ghanizadeh A, Sahraeizadeh A, Berk M.
    Child Psychiatry Hum Dev; 2014 Feb 25; 45(2):185-92. PubMed ID: 23801256
    [Abstract] [Full Text] [Related]

  • 12. Does Pregnenolone Adjunct to Risperidone Ameliorate Irritable Behavior in Adolescents With Autism Spectrum Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial?
    Ayatollahi A, Bagheri S, Ashraf-Ganjouei A, Moradi K, Mohammadi MR, Akhondzadeh S.
    Clin Neuropharmacol; 2020 Feb 25; 43(5):139-145. PubMed ID: 32947424
    [Abstract] [Full Text] [Related]

  • 13. Risperidone in children with autism and serious behavioral problems.
    McCracken JT, McGough J, Shah B, Cronin P, Hong D, Aman MG, Arnold LE, Lindsay R, Nash P, Hollway J, McDougle CJ, Posey D, Swiezy N, Kohn A, Scahill L, Martin A, Koenig K, Volkmar F, Carroll D, Lancor A, Tierney E, Ghuman J, Gonzalez NM, Grados M, Vitiello B, Ritz L, Davies M, Robinson J, McMahon D, Research Units on Pediatric Psychopharmacology Autism Network.
    N Engl J Med; 2002 Aug 01; 347(5):314-21. PubMed ID: 12151468
    [Abstract] [Full Text] [Related]

  • 14. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
    Shea S, Turgay A, Carroll A, Schulz M, Orlik H, Smith I, Dunbar F.
    Pediatrics; 2004 Nov 01; 114(5):e634-41. PubMed ID: 15492353
    [Abstract] [Full Text] [Related]

  • 15. Resveratrol as adjunctive therapy in treatment of irritability in children with autism: A double-blind and placebo-controlled randomized trial.
    Hendouei F, Sanjari Moghaddam H, Mohammadi MR, Taslimi N, Rezaei F, Akhondzadeh S.
    J Clin Pharm Ther; 2020 Apr 01; 45(2):324-334. PubMed ID: 31714621
    [Abstract] [Full Text] [Related]

  • 16. A randomized double-blind placebo-controlled clinical trial of adjuvant buspirone for irritability in autism.
    Ghanizadeh A, Ayoobzadehshirazi A.
    Pediatr Neurol; 2015 Jan 01; 52(1):77-81. PubMed ID: 25451017
    [Abstract] [Full Text] [Related]

  • 17. Sulforaphane as an adjunctive treatment for irritability in children with autism spectrum disorder: A randomized, double-blind, placebo-controlled clinical trial.
    Momtazmanesh S, Amirimoghaddam-Yazdi Z, Moghaddam HS, Mohammadi MR, Akhondzadeh S.
    Psychiatry Clin Neurosci; 2020 Jul 01; 74(7):398-405. PubMed ID: 32347624
    [Abstract] [Full Text] [Related]

  • 18. A pilot double-blind placebo-controlled trial of pioglitazone as adjunctive treatment to risperidone: Effects on aberrant behavior in children with autism.
    Ghaleiha A, Rasa SM, Nikoo M, Farokhnia M, Mohammadi MR, Akhondzadeh S.
    Psychiatry Res; 2015 Sep 30; 229(1-2):181-7. PubMed ID: 26208985
    [Abstract] [Full Text] [Related]

  • 19. Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder.
    Rezaei V, Mohammadi MR, Ghanizadeh A, Sahraian A, Tabrizi M, Rezazadeh SA, Akhondzadeh S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct 01; 34(7):1269-72. PubMed ID: 20637249
    [Abstract] [Full Text] [Related]

  • 20. l -carnitine adjunct to risperidone for treatment of autism spectrum disorder-associated behaviors: a randomized, double-blind clinical trial.
    Nasiri M, Parmoon Z, Farahmand Y, Moradi A, Farahmand K, Moradi K, Basti FA, Mohammadi MR, Akhondzadeh S.
    Int Clin Psychopharmacol; 2024 Jul 01; 39(4):232-239. PubMed ID: 37551601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.